O. K. Bondarenko
O. K. Bondarenko has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Natalya V. Soldatkina
National Medical Research Centre for Oncology
17 shared publications - Yuriy A. Gevorkyan
National Medical Research Centre for Oncology
16 shared publications - Oleg Ivanovich Kit
National Medical Research Centre for Oncology, Rostov-on-Don, Russia
13 shared publications Ю. А. Геворкян
ФГБУ «НМИЦ онкологии» Минздрава России
9 shared publications- A. V. Dashkov
National Medical Research Centre for Oncology
8 shared publications - D. S. Petrov
National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation
7 shared publications
Latest Publications
- Open Access
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 34-48
Impact of combined treatment for rectal cancer on long-term outcomes
Purpose of the study . To analyze the effectiveness of combined treatment for rectal cancer and evaluate the impact of ileostomy closure timing on treatment outcomes. Patients and methods. A study of treatment outcomes in 250 patients with locally advanced rectal cancer was conducted to assess the influence of patient age, sex, tumor characteristics, and timing of ileostomy closure. From January 2020 to November 2025, patients underwent treatment and follow-up including radiotherapy with a total focal dose of 50–54 Gy combined with capecitabine- based radiosensitization, followed by low anterior resection of the rectum with preventive ileostomy formation. Results . A significant prognostic factor has been established – metastatic involvement of regional lymph nodes (pN2), which increases the risk of death by 3.6 times (p = 0.0001) and the risk of disease progression by 4.1 times (p = 0.0004). Factors such as patients' age, gender, distance from the lower edge of the tumor, the degree of differentiation, and tumor invasion into the colon wall did not show a significant impact on overall survival and progression-free survival rates, which may be due to the limitations of the study (recruitment of a homogeneous group of patients with uniform treatment). No significant differences were found in overall survival rates (p = 0.9573) and progression-free survival rates (p = 0.5278) between groups of patients with ileostomy closure within 2 months and more than 4 months after low anterior resection of the rectum. Closure of the ileostomy within 2 months was accompanied by a decrease in the total number of postoperative complications (p < 0.001), parastomal hernias (p = 0.004), elevated creatinine levels (p = 0.037), the incidence of diversion colitis (p < 0.001), and diarrhea (p = 0.001). Conclusion . The study confirmed the safety of the approach to closing the ileostomy within 2 months after radical surgery before the start of adjuvant chemotherapy in the combined treatment of rectal cancer. Early closure of the ileostomy is recommended in patients without involvement of regional lymph nodes (pN0) or with involvement of regional lymph nodes (pN1) in the absence of clinical and radiological signs of colorectal anastomosis insufficiency.
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 34-48
Open AccessImpact of combined treatment for rectal cancer on long-term outcomes
Purpose of the study . To analyze the effectiveness of combined treatment for rectal cancer and evaluate the impact of ileostomy closure timing on treatment outcomes. Patients and methods. A study of treatment outcomes in 250 patients with locally advanced rectal cancer was conducted to assess the influence of patient age, sex, tumor characteristics, and timing of ileostomy closure. From January 2020 to November 2025, patients underwent treatment and follow-up including radiotherapy with a total focal dose of 50–54 Gy combined with capecitabine- based radiosensitization, followed by low anterior resection of the rectum with preventive ileostomy formation. Results . A significant prognostic factor has been established – metastatic involvement of regional lymph nodes (pN2), which increases the risk of death by 3.6 times (p = 0.0001) and the risk of disease progression by 4.1 times (p = 0.0004). Factors such as patients' age, gender, distance from the lower edge of the tumor, the degree of differentiation, and tumor invasion into the colon wall did not show a significant impact on overall survival and progression-free survival rates, which may be due to the limitations of the study (recruitment of a homogeneous group of patients with uniform treatment). No significant differences were found in overall survival rates (p = 0.9573) and progression-free survival rates (p = 0.5278) between groups of patients with ileostomy closure within 2 months and more than 4 months after low anterior resection of the rectum. Closure of the ileostomy within 2 months was accompanied by a decrease in the total number of postoperative complications (p < 0.001), parastomal hernias (p = 0.004), elevated creatinine levels (p = 0.037), the incidence of diversion colitis (p < 0.001), and diarrhea (p = 0.001). Conclusion . The study confirmed the safety of the approach to closing the ileostomy within 2 months after radical surgery before the start of adjuvant chemotherapy in the combined treatment of rectal cancer. Early closure of the ileostomy is recommended in patients without involvement of regional lymph nodes (pN0) or with involvement of regional lymph nodes (pN1) in the absence of clinical and radiological signs of colorectal anastomosis insufficiency.
- 26 March 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 3,p. 26-32
The results of surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone
Objective. The aim of the study — to study the immediate and long-term results of surgical interventions for colon cancer with spread to the organs of the pancreatic duodenal zone. Research methods. A retrospective analysis of 38 cases of treatment of malignant tumors of the colon involving the pancreatoduodenal zone in the Federal State Budgetary Institution “NMIC of Oncology” of the Ministry of Health of the Russian Federation from 2013 to 2024 was carried out. All patients underwent combined surgical procedures, including right- or left-sided hemicolectomy with duodenal resection (34.2%), atypical or distal pancreatic resection (26.3%), corporocaudal pancreatic resection (21.1%), pancreatoduodenal resection (18.4%). Results. The average volume of intraoperative blood loss was 300 ml, and the average duration of surgery was 280 minutes. The greatest volume of intraoperative blood loss and duration of surgery were observed in combined hemicolectomy with corporocaudal resection of the pancreas. Postoperative complications developed in 15 out of 38 patients (39.5%). Postoperative pancreatitis (13.2%), pancreatic necrosis, external pancreatic fistula and intra-abdominal bleeding (5.3% each) and repeated surgical interventions prevailed 4 (10.5%) patients were treated (ileotransverzoanastomosis failure, small intestine perforation, intra-abdominal bleeding, pancreatic necrosis). Two cases resulted in death in the early postoperative period (5.3%). To date, 15 out of 38 patients (39.5%) are alive, 23 (60.5%) patients have died. The 75%, 50%, and 25% survival rates of the subgroup of patients with duodenal resection were 4.5, 22.5, and 45.3 months, respectively. Conclusion. Surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone are technically complex surgical interventions, with a frequency of postoperative complications and a postoperative mortality rate above the average for colon cancer. Nevertheless, in combination with chemotherapy, they can achieve good long-term treatment results.
- 26 March 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 3,p. 26-32
The results of surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone
Objective. The aim of the study — to study the immediate and long-term results of surgical interventions for colon cancer with spread to the organs of the pancreatic duodenal zone. Research methods. A retrospective analysis of 38 cases of treatment of malignant tumors of the colon involving the pancreatoduodenal zone in the Federal State Budgetary Institution “NMIC of Oncology” of the Ministry of Health of the Russian Federation from 2013 to 2024 was carried out. All patients underwent combined surgical procedures, including right- or left-sided hemicolectomy with duodenal resection (34.2%), atypical or distal pancreatic resection (26.3%), corporocaudal pancreatic resection (21.1%), pancreatoduodenal resection (18.4%). Results. The average volume of intraoperative blood loss was 300 ml, and the average duration of surgery was 280 minutes. The greatest volume of intraoperative blood loss and duration of surgery were observed in combined hemicolectomy with corporocaudal resection of the pancreas. Postoperative complications developed in 15 out of 38 patients (39.5%). Postoperative pancreatitis (13.2%), pancreatic necrosis, external pancreatic fistula and intra-abdominal bleeding (5.3% each) and repeated surgical interventions prevailed 4 (10.5%) patients were treated (ileotransverzoanastomosis failure, small intestine perforation, intra-abdominal bleeding, pancreatic necrosis). Two cases resulted in death in the early postoperative period (5.3%). To date, 15 out of 38 patients (39.5%) are alive, 23 (60.5%) patients have died. The 75%, 50%, and 25% survival rates of the subgroup of patients with duodenal resection were 4.5, 22.5, and 45.3 months, respectively. Conclusion. Surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone are technically complex surgical interventions, with a frequency of postoperative complications and a postoperative mortality rate above the average for colon cancer. Nevertheless, in combination with chemotherapy, they can achieve good long-term treatment results.
- 9 September 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9,p. 29-35
Treatment of cancer in tubular villous colorectal adenomas
Objective. To study the results of treatment of cancer in tubular villous colorectal adenomas. Material and methods. A retrospective analysis included 51 patients with cancer in tubular villous colorectal adenomas cTis-T1N0M0 between 02.2019 and 09.2021. The median age of patients was 64 (57; 71) years. Minimally invasive interventions were performed in all patients (transanal endoscopic microsurgical resection of the rectum — 25 cases, endoscopic submucosal dissection — 20 cases, laparoscopic resection of the intestine — 6 cases). Results. Intraoperative complications (intestinal wall perforation) developed in 1 (2%) patient, early postoperative complications (intestinal bleeding from suture line) — in 2 (4%) patients. Throughout the follow-up period (29—84 months), tumor recurrence was detected in 2 (4%) patients with rectal primary tumor, colorectal polyps — in 8 (15.7%) patients. Eleven (21.6%) patients had previous malignant tumors. Conclusion. The study demonstrated favorable oncological and surgical results of treatment of cancer in tubular villous colorectal adenomas. Minimally invasive interventions are safe and predictable, as well as accompanied by low incidence of complications.
- 9 September 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9,p. 29-35
Treatment of cancer in tubular villous colorectal adenomas
Objective. To study the results of treatment of cancer in tubular villous colorectal adenomas. Material and methods. A retrospective analysis included 51 patients with cancer in tubular villous colorectal adenomas cTis-T1N0M0 between 02.2019 and 09.2021. The median age of patients was 64 (57; 71) years. Minimally invasive interventions were performed in all patients (transanal endoscopic microsurgical resection of the rectum — 25 cases, endoscopic submucosal dissection — 20 cases, laparoscopic resection of the intestine — 6 cases). Results. Intraoperative complications (intestinal wall perforation) developed in 1 (2%) patient, early postoperative complications (intestinal bleeding from suture line) — in 2 (4%) patients. Throughout the follow-up period (29—84 months), tumor recurrence was detected in 2 (4%) patients with rectal primary tumor, colorectal polyps — in 8 (15.7%) patients. Eleven (21.6%) patients had previous malignant tumors. Conclusion. The study demonstrated favorable oncological and surgical results of treatment of cancer in tubular villous colorectal adenomas. Minimally invasive interventions are safe and predictable, as well as accompanied by low incidence of complications.
- Open Access
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 106-114
The effect of the timing of the elimination of preventive ileostomy on the incidence of severe low anterior resection syndrome
AIM: to study the effect of early ileostomy closure on the incidence of low anterior resection syndrome (LARS) in patients with rectal cancer.PATIENTS AND METHODS: one-hundred patients with rectal cancer underwent radiation therapy with a total focal dose of 50-54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The primary endpoint of the study was the incidence of significant anorectal dysfunction at 3 months after ileostomy closure. Secondary endpoints included the incidence and severity of clinical manifestations of anorectal dysfunction, anal incontinence score according to the Wexner scale, overall distribution of anorectal dysfunction (absent, mild, severe) and the incidence of postoperative complications. Patients were randomized into two groups: with early ileostomy closure within 6 (5; 7) weeks after low anterior rectal resection (50 patients) and with late ileostomy closure after 24.5 (20; 29) weeks (50 patients). Three months after ileostomy closure, a questionnaire was done using the LARS and Wexner scales.RESULTS OF THE STUDY: the results obtained at 3 months after ileostomy closure showed advantages of the early ileostomy closure group. According to the GIFO scale, clinical manifestations of anorectal dysfunction were significantly less common in this group (p < 0.05). According to the LARS scale, the incidence of anorectal dysfunction in the early ileostomy closure group was 40%, while in the late closure group it was 70% (OR (odds ratio) = 3.50; 95% CI (confidence interval): 1.49–8.23; p = 0.0046). Moreover, severe LARS was detected in 6% and 26% of patients, respectively (OR = 0.12; 95% CI: 0.03–0.43; p = 0.012). The Wexner scale score was also significantly better in the early closure group (5 (4; 8) points) compared to the late closure group (9 (8; 10) points, p < 0.0001). With regard to the complications that developed in the late ileostomy closure group, a significantly higher incidence of colitis was noted (21/50 (42%) versus 6/50 (12%) cases, p = 0.0014).CONCLUSION: in the course of the conducted work it was established that 3 months after ileostomy closure, patients in the early closure group showed less manifestations of anorectal dysfunction compared to patients in the late closure group.
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 106-114
Open AccessThe effect of the timing of the elimination of preventive ileostomy on the incidence of severe low anterior resection syndrome
AIM: to study the effect of early ileostomy closure on the incidence of low anterior resection syndrome (LARS) in patients with rectal cancer.PATIENTS AND METHODS: one-hundred patients with rectal cancer underwent radiation therapy with a total focal dose of 50-54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The primary endpoint of the study was the incidence of significant anorectal dysfunction at 3 months after ileostomy closure. Secondary endpoints included the incidence and severity of clinical manifestations of anorectal dysfunction, anal incontinence score according to the Wexner scale, overall distribution of anorectal dysfunction (absent, mild, severe) and the incidence of postoperative complications. Patients were randomized into two groups: with early ileostomy closure within 6 (5; 7) weeks after low anterior rectal resection (50 patients) and with late ileostomy closure after 24.5 (20; 29) weeks (50 patients). Three months after ileostomy closure, a questionnaire was done using the LARS and Wexner scales.RESULTS OF THE STUDY: the results obtained at 3 months after ileostomy closure showed advantages of the early ileostomy closure group. According to the GIFO scale, clinical manifestations of anorectal dysfunction were significantly less common in this group (p < 0.05). According to the LARS scale, the incidence of anorectal dysfunction in the early ileostomy closure group was 40%, while in the late closure group it was 70% (OR (odds ratio) = 3.50; 95% CI (confidence interval): 1.49–8.23; p = 0.0046). Moreover, severe LARS was detected in 6% and 26% of patients, respectively (OR = 0.12; 95% CI: 0.03–0.43; p = 0.012). The Wexner scale score was also significantly better in the early closure group (5 (4; 8) points) compared to the late closure group (9 (8; 10) points, p < 0.0001). With regard to the complications that developed in the late ileostomy closure group, a significantly higher incidence of colitis was noted (21/50 (42%) versus 6/50 (12%) cases, p = 0.0014).CONCLUSION: in the course of the conducted work it was established that 3 months after ileostomy closure, patients in the early closure group showed less manifestations of anorectal dysfunction compared to patients in the late closure group.
- Open Access
- 12 November 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (4) , 40-47
Prediction of anorectal dysfunction in the combined treatment of rectal cancer
AIM: to assess the risk of severe low anterior resection syndrome (LARS) in patients with rectal cancer after combined treatment.PATIENTS AND METHODS: from July 2022 to November 2023, 50 patients with rectal cancer underwent radiation with a total focal dose of 50–54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The ileostomy was closed after 4 months. Prior to and after radiation, the anorectal function was assessed using high-resolution anorectal manometry (HRAM) and the LARS scale.RESULTS: the most significant predicting factors for severe LARS were maximal contraction pressure and first sensation volume. Three months after ileostomy closure, the patients were divided into groups depending on the HRAM parameters. Group 1: nine patients with severe LARS (34 points on the LARS scale), with a decrease in maximal contraction pressure by ≥ 30% and an increased first sensation volume by ≥ 60%, according to HRAM. Group 2: four patients out of 36 had severe LARS (31 points on the LARS scale), with a decrease in maximal contraction pressure by 5–29% and an increased first sensation volume by 10–59%, according to HRAM. Group 3: in 5 patients with a decreased maximal contraction pressure by ≤ 4% and an increased volume of the first sensation by ≤ 9%, LARS did not develop.CONCLUSION: a decrease in the maximal contraction pressure by 30% or more and an increase in the volume of the first sensation by 60% or more after radiation therapy can increase the risk of severe LARS. This group of patients requires prevention and correction of anorectal dysfunction.
- 12 November 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (4) , 40-47
Open AccessPrediction of anorectal dysfunction in the combined treatment of rectal cancer
AIM: to assess the risk of severe low anterior resection syndrome (LARS) in patients with rectal cancer after combined treatment.PATIENTS AND METHODS: from July 2022 to November 2023, 50 patients with rectal cancer underwent radiation with a total focal dose of 50–54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The ileostomy was closed after 4 months. Prior to and after radiation, the anorectal function was assessed using high-resolution anorectal manometry (HRAM) and the LARS scale.RESULTS: the most significant predicting factors for severe LARS were maximal contraction pressure and first sensation volume. Three months after ileostomy closure, the patients were divided into groups depending on the HRAM parameters. Group 1: nine patients with severe LARS (34 points on the LARS scale), with a decrease in maximal contraction pressure by ≥ 30% and an increased first sensation volume by ≥ 60%, according to HRAM. Group 2: four patients out of 36 had severe LARS (31 points on the LARS scale), with a decrease in maximal contraction pressure by 5–29% and an increased first sensation volume by 10–59%, according to HRAM. Group 3: in 5 patients with a decreased maximal contraction pressure by ≤ 4% and an increased volume of the first sensation by ≤ 9%, LARS did not develop.CONCLUSION: a decrease in the maximal contraction pressure by 30% or more and an increase in the volume of the first sensation by 60% or more after radiation therapy can increase the risk of severe LARS. This group of patients requires prevention and correction of anorectal dysfunction.
- Open Access
- 19 September 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (3) , 102-110
Modern strategy of metastatic colorectal cancer treatment (literature review)
Современные хирургические стратегии лечения метастатического колоректального рака (обзор литературы)
- 19 September 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (3) , 102-110
Open AccessModern strategy of metastatic colorectal cancer treatment (literature review)
Современные хирургические стратегии лечения метастатического колоректального рака (обзор литературы)
- 15 July 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 25-35
D2 and D3 lymph node dissection for colon cancer
Objective. To evaluate surgical and oncological results of standard and extended lymph node dissection (D2 and D3) in patients with colon cancer. Material and methods. We analyzed treatment outcomes in 74 patients with colon cancer stage T1-4aN0-2M0 who underwent right- and left-sided hemicolectomy, resection of sigmoid colon with standard and extended lymph node dissection (D2 and D3). Results. Surgical approach and level of D3 lymph node dissection did not increase intra- and postoperative morbidity. Laparoscopic interventions were followed by significantly lower intraoperative blood loss and earlier gas discharge. Metastatic lesion of apical lymph nodes was observed in 5 out of 36 patients who underwent D3 lymph node dissection (13.8%), and metastases in regional lymph nodes rN1-2 were found in all these patients. Overall 5-year survival was 86%. Disease-free and overall 5-year survival were similar after D2 and D3 lymph node dissection. Conclusion. D3 lymph node dissection is safe for colon cancer. Metastatic lesions of apical lymph nodes during D3 lymph node dissection were detected only in patients with lesions of regional lymph nodes (rN1-2). Disease-free and overall 5-year survival were similar after D2 and D3 lymph node dissection.
- 15 July 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 25-35
D2 and D3 lymph node dissection for colon cancer
Objective. To evaluate surgical and oncological results of standard and extended lymph node dissection (D2 and D3) in patients with colon cancer. Material and methods. We analyzed treatment outcomes in 74 patients with colon cancer stage T1-4aN0-2M0 who underwent right- and left-sided hemicolectomy, resection of sigmoid colon with standard and extended lymph node dissection (D2 and D3). Results. Surgical approach and level of D3 lymph node dissection did not increase intra- and postoperative morbidity. Laparoscopic interventions were followed by significantly lower intraoperative blood loss and earlier gas discharge. Metastatic lesion of apical lymph nodes was observed in 5 out of 36 patients who underwent D3 lymph node dissection (13.8%), and metastases in regional lymph nodes rN1-2 were found in all these patients. Overall 5-year survival was 86%. Disease-free and overall 5-year survival were similar after D2 and D3 lymph node dissection. Conclusion. D3 lymph node dissection is safe for colon cancer. Metastatic lesions of apical lymph nodes during D3 lymph node dissection were detected only in patients with lesions of regional lymph nodes (rN1-2). Disease-free and overall 5-year survival were similar after D2 and D3 lymph node dissection.
- Open Access
- 28 May 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (2) , 25-34
Features of anorectal function after radiation therapy in patients with rectal cancer
Purpose of the study. To study the function of the sphincter in patients with rectal cancer after chemoradiotherapy using the method of high-resolution anorectal manometry.Materials and methods. The study included 30 patients with cancer of the middle and lower ampullary rectum, who underwent combined treatment at the National Medical Research Center of Oncology. The patients underwent a course of neoadjuvant gamma radiation therapy using capecitabine. High-resolution anorectal manometry was performed before the start of treatment and 2 months after completion of chemoradiotherapy to study the functional parameters of the sphincter apparatus. The severity of anorectal dysfunction was assessed using the Wexner anal incontinence scale.Results. According to high-resolution anorectal manometry, the average pressure of the anal canal at rest decreased by 1.4 times (p < 0.05), and the average absolute compression pressure with voluntary contraction decreased by 1.2 times (p = 0.0012) after neoadjuvant chemoradiotherapy. A comparative assessment of the maximum absolute compression pressure at this stage of treatment did not allow us to trace a significant difference between its value before the start of radiation therapy and 2 months after its completion (p > 0.05). An increase in threshold sensitivity volumes was noted in 23 patients (p = 0.16). The use of the Wexner scale didn’t show a statistically significant change in the median scores according to the results of patient surveys following the completion of treatment (5.2 vs. 5.5 points, p > 0.05).Conclusions. Radiation therapy has an effect on anorectal function, which may contribute to the occurrence of low anterior resection syndrome after surgical treatment. For this reason, it is now necessary to carefully consider the risks of developing anorectal dysfunction. Equally important is the use of methods for the prevention of low anterior resection syndrome for patients who have received combined treatment for rectal cancer.
- 28 May 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (2) , 25-34
Open AccessFeatures of anorectal function after radiation therapy in patients with rectal cancer
Purpose of the study. To study the function of the sphincter in patients with rectal cancer after chemoradiotherapy using the method of high-resolution anorectal manometry.Materials and methods. The study included 30 patients with cancer of the middle and lower ampullary rectum, who underwent combined treatment at the National Medical Research Center of Oncology. The patients underwent a course of neoadjuvant gamma radiation therapy using capecitabine. High-resolution anorectal manometry was performed before the start of treatment and 2 months after completion of chemoradiotherapy to study the functional parameters of the sphincter apparatus. The severity of anorectal dysfunction was assessed using the Wexner anal incontinence scale.Results. According to high-resolution anorectal manometry, the average pressure of the anal canal at rest decreased by 1.4 times (p < 0.05), and the average absolute compression pressure with voluntary contraction decreased by 1.2 times (p = 0.0012) after neoadjuvant chemoradiotherapy. A comparative assessment of the maximum absolute compression pressure at this stage of treatment did not allow us to trace a significant difference between its value before the start of radiation therapy and 2 months after its completion (p > 0.05). An increase in threshold sensitivity volumes was noted in 23 patients (p = 0.16). The use of the Wexner scale didn’t show a statistically significant change in the median scores according to the results of patient surveys following the completion of treatment (5.2 vs. 5.5 points, p > 0.05).Conclusions. Radiation therapy has an effect on anorectal function, which may contribute to the occurrence of low anterior resection syndrome after surgical treatment. For this reason, it is now necessary to carefully consider the risks of developing anorectal dysfunction. Equally important is the use of methods for the prevention of low anterior resection syndrome for patients who have received combined treatment for rectal cancer.
- Open Access
- 27 February 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (1) , 52-58
Results of rectal resection in metastatic cancer
Результаты резекции прямой кишки при метастатическом раке
- 27 February 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (1) , 52-58
Open AccessResults of rectal resection in metastatic cancer
Результаты резекции прямой кишки при метастатическом раке
- Open Access
- 1 December 2023
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 22 (4) , 104-112
Individual approach to metastatic colorectal cancer treatment (clinical cases)
Two patients with metastatic colorectal cancer underwent R0 large bowel resection followed by surgery liver and lungs metastases, retroperitoneal lymph nodes and post-op chemotherapy. The total follow-up period of the first patient was currently 12 years, the recurrence-free period was 5 years. In the second patient, stabilization of the disease was observed for 12 years, and the total follow-up period – 18.5 years. An integrated treatment approach to metastatic CRC with active surgery for removable distant metastases or perioperative use of the most effective drug therapy for potentially resectable metastases can control the disease even with an aggressive course.
- 1 December 2023
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 22 (4) , 104-112
Open AccessIndividual approach to metastatic colorectal cancer treatment (clinical cases)
Two patients with metastatic colorectal cancer underwent R0 large bowel resection followed by surgery liver and lungs metastases, retroperitoneal lymph nodes and post-op chemotherapy. The total follow-up period of the first patient was currently 12 years, the recurrence-free period was 5 years. In the second patient, stabilization of the disease was observed for 12 years, and the total follow-up period – 18.5 years. An integrated treatment approach to metastatic CRC with active surgery for removable distant metastases or perioperative use of the most effective drug therapy for potentially resectable metastases can control the disease even with an aggressive course.